½ÃÀ庸°í¼­
»óǰÄÚµå
1279883

¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : À¯Çüº°(½ÉÀå º¸Ã¶Àåºñ, Ç÷°ü º¸Ã¶Àåºñ), ÃÖÁ¾ »ç¿ëÀÚº°(º´¿ø, Áø·á¼Ò, ±âŸ), Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Cardiovascular Prosthetic Devices Market Size study & Forecast, by Type( Cardiac prosthetic devices, Vascular Prosthetic Devices) by End User (Hospitals, Clinics, Others) and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀåÀº 2022³â ¾à 269¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 8.6% ÀÌ»óÀÇ °ÇÀüÇÑ ¼ºÀå·ü·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º´Â ½ÉÇ÷°ü ½Ã½ºÅÛÀÇ ±â´ÉÀ» ´ëüÇϰųª Áö¿øÇϱâ À§ÇØ ¼³°èµÈ ÀÇ·á±â±âÀÔ´Ï´Ù. À̵éÀº ÁÖ·Î ´Ù¾çÇÑ ½ÉÀå »óÅÂ¿Í Áúº´À» Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀåÀº ½ÉÇ÷°ü Áúȯ ¹× ¼ö¼úÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¼ºÀåÇϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î Centers for Disease Control and Prevention(CDC)ÀÌ ¹ßÇ¥ÇÑ ÀÚ·á¿¡ µû¸£¸é °ü»óµ¿¸Æ¼º ½ÉÀ庴Àº °¡Àå ÈçÇÑ Áúº´À¸·Î 2020³â ¹Ì±¹¿¡¼­ 38¸¸ 2820¸íÀÇ ¸ñ¼ûÀ» ¾Ñ¾Æ°©´Ï´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ 65¼¼ ¹Ì¸¸ ¼ºÀÎÀÇ °ü»óµ¿¸ÆÁúȯ(CAD)À¸·Î ÀÎÇÑ »ç¸ÁÀº 2020³â ¾à 10¸í Áß 2¸í²Ã·Î ¹ß»ýÇÑ´Ù°í ÇÕ´Ï´Ù. ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽ºÀÇ »ç¿ëÀº ½ÉÇ÷°ü ¼ö¼ú Áõ°¡·Î ÀÎÇØ ÃËÁøµÉ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ±¹¸³ ÀÇÇÐ µµ¼­°üÀº 2022³â 9¿ù ¼¼°è¿¡¼­ ¿¬°£ 20¸¸ °Ç ÀÌ»óÀÇ ½ÉÀå ÆÇ¸· ±³Ã¼ ¼ö¼úÀÌ ÀÌ·ç¾îÁö°í ÀÖÀ¸¸ç, 2050³â¿¡´Â ¿¬°£ 8,50,000 °ÇÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÈ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ °ü»óµ¿¸Æ¿ìȸ¼ú(CABG)Àº ¿¬°£ 40¸¸ °Ç¿¡ À°¹ÚÇϸç ÁÖ¿ä ¼ö¼ú Áß °¡Àå ÈçÇÑ ¼ö¼ú·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù. ÀÌó·³ ½ÉÀå Áúȯ Áõ°¡¿Í ¼ö¼ú °Ç¼ö Áõ°¡°¡ ½ÃÀå ¼ºÀåÀ» °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ±â¼ú ¹ßÀü Áõ°¡¿Í À¯¸®ÇÑ ÀÇ·áºñ »óȯ Á¤Ã¥Àº ½ÃÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽ºÀÇ °íºñ¿ëÀ¸·Î ÀÎÇØ 2023-2030³âÀÇ ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» ÀúÇØÇϰí ÀÖ½À´Ï´Ù.

¼¼°è ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÇ´Â ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù. ºÏ¹Ì´Â ½ÉÀå Áúȯ Áõ°¡, ÁÖ¿ä ½ÃÀå ±â¾÷ÀÇ Á¸Àç, ÀÌ Áö¿ªÀÇ ±â¼ú ¹ßÀü Áõ°¡·Î ÀÎÇØ 2022³â ½ÃÀåÀ» Áö¹èÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ³ëÀÎ ¹× Áúº´ Áõ°¡, Á¦Ç° °³¹ßÀ» À§ÇÑ °øµ¿ ¿¬±¸ Áõ°¡, ÁÖ¿ä ±â¾÷ÀÇ Áö¿ªÀû È®Àå, Á¤ºÎ ±â°ü ¹× ºñ¿µ¸® ´Üü ½ÃÀå ÁøÀÔ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¿¹Ãø ±â°£ Áß Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ¿¬±¸ÀÇ ¸ñÀûÀº ÃÖ±Ù ¼ö³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¼ö³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦ µî Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ±â¾÷ÀÇ °æÀï ȯ°æ°ú °æÀï ±¸µµ¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¹Ì½ÃÀû ½ÃÀå¿¡¼­ÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ½º³À¼ô
  • ¼¼°è ½ÃÀ塤ºÎ¹®º° ½ÃÀå Ã߻ꡤ¿¹Ãø,2020-2030³â
    • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : Áö¿ªº°, 2020-2030³â
    • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°, 2020-2030³â
    • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, 2020-2030³â
  • ÁÖ¿ä µ¿Çâ
  • Á¶»ç ¹æ¹ý
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç

Á¦2Àå ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀåÀÇ Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • º» Á¶»çÀÇ ´ë»ó ¹üÀ§
  • Á¶»ç ´ë»ó³â
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ¿ªÇÐ

  • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ÃËÁø¿äÀÎ
      • ½ÉÇ÷°üÁúȯ ¹× ¼ö¼úÀÇ À¯º´·ü Áõ°¡
      • ³ë³â Àα¸ÀÇ Áõ°¡
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦
      • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽ºÀÇ °íºñ¿ë
    • ½ÃÀå ±âȸ
      • ±â¼úÀû Áøº¸ÀÇ Áõ°¡
      • À¯¸®ÇÑ ÀÇ·áºñ »óȯ Á¤Ã¥

Á¦4Àå ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô ÁøÃâ¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷°£ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦Àû
    • »çȸÀû
    • ±â¼úÀû
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ ½ÃÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ Á¦¾È°ú °á·Ð

Á¦5Àå ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : À¯Çüº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå, À¯Çüº° ÃßÁ¤¡¤¿¹Ãø 2020-2030
  • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • ½ÉÀå º¸Ã¶ µð¹ÙÀ̽º
    • Ç÷°ü º¸Ã¶ µð¹ÙÀ̽º

Á¦6Àå ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ½º³À¼ô
  • ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°, ½ÇÀû - ÀáÀç·Â ºÐ¼®
  • ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø 2020-2030
  • ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå, ÇÏÀ§ ºÎ¹®º° ºÐ¼®
    • º´¿ø
    • Áø·á¼Ò
    • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå : Áö¿ªº° ºÐ¼®

  • »óÀ§ÀÇ ÁÖ¿ä ±¹°¡
  • »óÀ§ ½ÅÈï ±¹°¡
  • ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå, Áö¿ªº° ½ÃÀå ½º³À¼ô
  • ºÏ¹Ì
    • ¹Ì±¹
      • À¯Çüº° ÃßÁ¤¡¤¿¹Ãø,2020-2030³â
      • ÃÖÁ¾»ç¿ëÀÚº° ÃßÁ¤¡¤¿¹Ãø,2020-2030³â
    • ij³ª´Ù
  • À¯·´ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ½º³À¼ô
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ½º³À¼ô
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ½ÉÇ÷°ü º¸Ã¶ µð¹ÙÀ̽º ½ÃÀå ½º³À¼ô
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®
  • TOP ¸¶ÄÏ Àü·«
  • ±â¾÷ °³¿ä
    • B Braun Melsungen AG
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫 Á¤º¸(µ¥ÀÌÅÍ ÀÔ¼ö°¡ °¡´ÉÇÑ °æ¿ì¸¸)
      • Á¦Ç° °³¿ä
      • ÃÖ±Ù µ¿Çâ
    • Boston Scientific Corporation
    • Artivion, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Edwards Lifesciences Private Ltd
    • Medtronic plc
    • Johnson and Johnson Pvt Ltd
    • W. L. Gore & Associates, Inc.
    • Abbott Laboratories Inc
    • Biotronic Inc

Á¦9Àå Á¶»ç ÇÁ·Î¼¼½º

  • Á¶»ç ÇÁ·Î¼¼½º
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»çÀÇ Æ¯Â¡
  • Á¶»çÀÇ ÀüÁ¦Á¶°Ç
KSA 23.06.13

Global Cardiovascular Prosthetic Devices Market is valued approximately USD 26.94 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 8.6% over the forecast period 2023-2030. Cardiovascular prosthetic devices are medical devices designed to replace or support the function of the cardiovascular system. They are primarily used in the treatment of various heart conditions and diseases. The Cardiovascular Prosthetic Devices market is expanding because of factors such as an increase in the prevalence of cardiovascular disorders and surgeries and growing geriatric population.

For instance, according to a data released by the Centres for Disease Control and Prevention (CDC), coronary heart disease is the most prevalent form of the disease and claimed 382,820 lives in the United States in 2020. Additionally, about 2 in 10 deaths from coronary artery disease (CAD) in adults under 65 years of age will occur in 2020. The use of cardiovascular prosthetic devices is expected to be driven by the rise in cardiovascular procedures, which will also fuel market expansion. For instance, the National Library of Medicine announced in September 2022 that more than 200,000 heart valve replacement procedures are carried out annually worldwide, with an increase to 8,50,000 per year expected by 2050. Additionally, nearly 400,000 coronary artery bypass grafting (CABG) surgeries are performed annually, making it the most common major surgical procedure. Thus, rising prevelance of cardiac disorders and the increase in number of surgeries performed is fostering the market growth. In addition, rising technological advancements and favorable Health Reimbursement Policies are creating a lucrative opportunity to the market. However, the high cost of Cardiovascular Prosthetic Devices stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cardiovascular Prosthetic Devices Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising prevelance cardiac disorders, presence of key market players, and rising technological advancements in the region. Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising geriatric and diseases prevelance, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • B Braun Melsungen AG
  • Boston Scientific Corporation
  • Artivion, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Edwards Lifesciences Private Ltd
  • Medtronic plc
  • Johnson and Johnson Pvt Ltd
  • W. L. Gore & Associates, Inc.
  • Abbott Laboratories Inc
  • Biotronic Inc

Recent Developments in the Market:

  • In September 2021, The FDA has authorized the company's Epic Plus and Epic Plus Supra Stented Tissue Valves, expanding the range of treatment choices for patients with aortic or mitral valve dysfunction, according to Abbott Laboratories, a manufacturer of pharmaceuticals and medical equipment.
  • In January 2022, The School of Medical Research and Technology (SMRT) of IIT Kanpur launched the Hridyantra challenge-based programme to develop an advanced artificial heart, also known as a Left Ventricular Assist device (LVAD), for patients with end-stage heart failure.

Global Cardiovascular Prosthetic Devices Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Type, End User, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Typeofferings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

  • Cardiac prosthetic devices
  • Vascular Prosthetic Devices

By End User:

  • Hospitals
  • Clinics
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Cardiovascular Prosthetic Devices Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Cardiovascular Prosthetic Devices Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Cardiovascular Prosthetic Devices Market, by End User, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cardiovascular Prosthetic Devices Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cardiovascular Prosthetic Devices Market Dynamics

  • 3.1. Cardiovascular Prosthetic Devices Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in the prevalence of cardiovascular disorders and surgeries
      • 3.1.1.2. Growing Geriatric Population
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Cardiovascular Prosthetic Devices
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising technological advancements
      • 3.1.3.2. Favourable Health Reimbursement Policies

Chapter 4. Global Cardiovascular Prosthetic Devices Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cardiovascular Prosthetic Devices Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cardiovascular Prosthetic Devices Market by Type, Performance - Potential Analysis
  • 5.3. Global Cardiovascular Prosthetic Devices Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Cardiovascular Prosthetic Devices Market, Sub Segment Analysis
    • 5.4.1. Cardiac prosthetic devices
    • 5.4.2. Vascular Prosthetic Devices

Chapter 6. Global Cardiovascular Prosthetic Devices Market, by End User

  • 6.1. Market Snapshot
  • 6.2. Global Cardiovascular Prosthetic Devices Market by End User, Performance - Potential Analysis
  • 6.3. Global Cardiovascular Prosthetic Devices Market Estimates & Forecasts by End User 2020-2030 (USD Billion)
  • 6.4. Cardiovascular Prosthetic Devices Market, Sub Segment Analysis
    • 6.4.1. Hospitals
    • 6.4.2. Clinics
    • 6.4.3. Others

Chapter 7. Global Cardiovascular Prosthetic Devices Market, Regional Analysis

  • 7.1. Top Leading Countries
  • 7.2. Top Emerging Countries
  • 7.3. Cardiovascular Prosthetic Devices Market, Regional Market Snapshot
  • 7.4. North America Cardiovascular Prosthetic Devices Market
    • 7.4.1. U.S. Cardiovascular Prosthetic Devices Market
      • 7.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 7.4.1.2. End User breakdown estimates & forecasts, 2020-2030
    • 7.4.2. Canada Cardiovascular Prosthetic Devices Market
  • 7.5. Europe Cardiovascular Prosthetic Devices Market Snapshot
    • 7.5.1. U.K. Cardiovascular Prosthetic Devices Market
    • 7.5.2. Germany Cardiovascular Prosthetic Devices Market
    • 7.5.3. France Cardiovascular Prosthetic Devices Market
    • 7.5.4. Spain Cardiovascular Prosthetic Devices Market
    • 7.5.5. Italy Cardiovascular Prosthetic Devices Market
    • 7.5.6. Rest of Europe Cardiovascular Prosthetic Devices Market
  • 7.6. Asia-Pacific Cardiovascular Prosthetic Devices Market Snapshot
    • 7.6.1. China Cardiovascular Prosthetic Devices Market
    • 7.6.2. India Cardiovascular Prosthetic Devices Market
    • 7.6.3. Japan Cardiovascular Prosthetic Devices Market
    • 7.6.4. Australia Cardiovascular Prosthetic Devices Market
    • 7.6.5. South Korea Cardiovascular Prosthetic Devices Market
    • 7.6.6. Rest of Asia Pacific Cardiovascular Prosthetic Devices Market
  • 7.7. Latin America Cardiovascular Prosthetic Devices Market Snapshot
    • 7.7.1. Brazil Cardiovascular Prosthetic Devices Market
    • 7.7.2. Mexico Cardiovascular Prosthetic Devices Market
  • 7.8. Middle East & Africa Cardiovascular Prosthetic Devices Market
    • 7.8.1. Saudi Arabia Cardiovascular Prosthetic Devices Market
    • 7.8.2. South Africa Cardiovascular Prosthetic Devices Market
    • 7.8.3. Rest of Middle East & Africa Cardiovascular Prosthetic Devices Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Company 1
    • 8.1.2. Company 2
    • 8.1.3. Company 3
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. B Braun Melsungen AG
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Recent Developments
    • 8.3.2. Boston Scientific Corporation
    • 8.3.3. Artivion, Inc.
    • 8.3.4. Meril Life Sciences Pvt. Ltd.
    • 8.3.5. Edwards Lifesciences Private Ltd
    • 8.3.6. Medtronic plc
    • 8.3.7. Johnson and Johnson Pvt Ltd
    • 8.3.8. W. L. Gore & Associates, Inc.
    • 8.3.9. Abbott Laboratories Inc
    • 8.3.10. Biotronic Inc

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦